• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Kirk McDonald Appointed to Ziff Davis Board of Directors

    11/16/23 4:35:00 PM ET
    $ELAN
    $ZD
    Biotechnology: Pharmaceutical Preparations
    Health Care
    Telecommunications Equipment
    Telecommunications
    Get the next $ELAN alert in real time by email

    Ziff Davis, Inc. (NASDAQ:ZD), today announced the appointment of Kirk McDonald to its Board of Directors, effective November 15, 2023. McDonald is a highly accomplished executive with extensive experience and a career spanning more than three decades in media, technology, and advertising.

    "We are thrilled to welcome Kirk to our Board of Directors," said Ziff Davis Board Chair Sarah Fay. "As an industry veteran known for his business leadership, he will be an asset to Ziff Davis."

    McDonald serves as CEO of GroupM North America, a leading media investment agency. He announced that he will leave the role at year end. Prior to this, he was Chief Business Officer of Warner Media's Xandr when it was a division of AT&T. He was also President of Pubmatic, and has held executive level leadership roles at Time Inc., the Aquantive division of Microsoft, and CNET Networks. McDonald currently serves on the board of Elanco (NYSE:ELAN), and is a founding member of the Black Executive CMO Alliance. He also serves on the boards of directors of industry organizations including the Ad Council (as co-chair), the Paley Center for Media, and the Advertising Week Advisory Council. An alumnus of the City College of New York, Mr. McDonald majored in English as an undergraduate.

    "Kirk is widely respected in our industry, and has been a leader and innovator across a range of companies in the media and advertising ecosystem," said Ziff Davis CEO Vivek Shah.

    "I am delighted to be joining the Ziff Davis Board of Directors," McDonald said. "I look forward to working with Vivek and the entire Ziff Davis team across its portfolio of leading brands."

    About Ziff Davis

    Ziff Davis (NASDAQ:ZD) is a vertically focused digital media and internet company whose portfolio includes leading brands in technology, shopping, gaming and entertainment, connectivity, health, cybersecurity, and martech. For more information, visit www.ziffdavis.com.

    View source version on businesswire.com: https://www.businesswire.com/news/home/20231116449936/en/

    Get the next $ELAN alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $ELAN
    $ZD

    CompanyDatePrice TargetRatingAnalyst
    Elanco Animal Health Incorporated
    $ELAN
    1/22/2026Neutral → Overweight
    Piper Sandler
    Elanco Animal Health Incorporated
    $ELAN
    12/9/2025$30.00Overweight
    Barclays
    Elanco Animal Health Incorporated
    $ELAN
    11/21/2025$27.00Overweight
    KeyBanc Capital Markets
    Elanco Animal Health Incorporated
    $ELAN
    11/19/2025$25.00Hold → Buy
    Argus
    Elanco Animal Health Incorporated
    $ELAN
    10/7/2025$24.00Neutral → Overweight
    Analyst
    Elanco Animal Health Incorporated
    $ELAN
    7/17/2025$18.00Market Perform → Outperform
    Leerink Partners
    Elanco Animal Health Incorporated
    $ELAN
    6/26/2025Mkt Perform → Outperform
    William Blair
    Ziff Davis Inc.
    $ZD
    4/22/2025$33.00Overweight → Neutral
    Analyst
    More analyst ratings

    $ELAN
    $ZD
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    RetailMeNot Expands Savings Commitment with New Guaranteed Cash Back at Over 4,000 Retailers

    RetailMeNot now guarantees cash back with always-on rewards at more than 4,000 retailers, including newly added merchants funded directly by the company, and features over 10,000 retailers and brands with live offers across its platform, broadening access to savings for shoppers.The Guaranteed Cash Back program establishes an always-on savings foundation, giving shoppers a consistent baseline they can rely on and enabling stackable rewards across more purchases and categories than ever before.AUSTIN, Texas, Feb. 25, 2026 /PRNewswire/ -- Today, RetailMeNot, a Ziff Davis company, announced its new Guaranteed Cash Back program, establishing a new industry benchmark for consistent, stackable sav

    2/25/26 10:00:00 AM ET
    $ZD
    Telecommunications Equipment
    Telecommunications

    Elanco Animal Health Reports Fourth Quarter and Full Year 2025 Results

    Raising 2026 Innovation Target; Full Year 2026 Guidance of 4%-6% Organic Constant Currency Revenue Growth, 6%-9% Adjusted EBITDA Growth In Line with Investor Day OutlookFourth Quarter 2025 Financial Results:Revenue of $1,144 million, increased 12% on a reported basis; 9% in organic constant currencyReported Net Loss of $276 million, Adjusted Net Income of $64 millionAdjusted EBITDA of $189 million; Adjusted EBITDA Margin of 16.7%Reported EPS of $(0.56), Adjusted EPS of $0.13Full Year 2025 Financial Results:Exceeded innovation revenue target at $892 million; delivered all 'Big 6' blockbuster potential products by the end of 2025 with Befrena approval in Q4 2025Revenue of $4,715 million, incre

    2/24/26 6:27:00 AM ET
    $ELAN
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Ziff Davis Reports Fourth Quarter and Full Year 2025 Financial Results

    Ziff Davis, Inc. (NASDAQ:ZD) ("Ziff Davis" or "the Company") today reported unaudited financial results for the fourth quarter and year ended December 31, 2025. "In 2025, Ziff Davis grew Revenues, Adjusted EBITDA, and Adjusted diluted EPS, while generating almost $290 million in Free cash flow," said Vivek Shah, CEO of Ziff Davis. "We deployed $174 million in share repurchases during the year with the conviction that our share price does not adequately reflect the intrinsic value of our businesses." FOURTH QUARTER 2025 RESULTS Revenues (1) decreased to $406.7 million compared to $412.8 million for Q4 2024. Income from operations increased 9.6% to $86.0 million compared to $78.5 m

    2/23/26 6:00:00 PM ET
    $ZD
    Telecommunications Equipment
    Telecommunications

    $ELAN
    $ZD
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    SEC Form 4 filed by Officer Modi Rajeev A.

    4 - Elanco Animal Health Inc (0001739104) (Issuer)

    2/24/26 4:45:06 PM ET
    $ELAN
    Biotechnology: Pharmaceutical Preparations
    Health Care

    SEC Form 4 filed by PRESIDENT, CEO AND DIRECTOR Simmons Jeffrey N

    4 - Elanco Animal Health Inc (0001739104) (Issuer)

    2/24/26 4:44:20 PM ET
    $ELAN
    Biotechnology: Pharmaceutical Preparations
    Health Care

    SEC Form 4 filed by EVP and CFO Vanhimbergen Robert M

    4 - Elanco Animal Health Inc (0001739104) (Issuer)

    2/24/26 4:43:18 PM ET
    $ELAN
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $ELAN
    $ZD
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Kurzius Lawrence Erik bought $213,000 worth of shares (10,000 units at $21.30), increasing direct ownership by 8% to 131,773 units (SEC Form 4)

    4 - Elanco Animal Health Inc (0001739104) (Issuer)

    12/16/25 4:42:47 PM ET
    $ELAN
    Biotechnology: Pharmaceutical Preparations
    Health Care

    PRESIDENT, CEO AND DIRECTOR Simmons Jeffrey N bought $478,496 worth of shares (22,000 units at $21.75) (SEC Form 4)

    4 - Elanco Animal Health Inc (0001739104) (Issuer)

    12/15/25 4:41:24 PM ET
    $ELAN
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Officer Modi Rajeev A. bought $95,985 worth of shares (4,500 units at $21.33), increasing direct ownership by 4% to 123,082 units (SEC Form 4)

    4 - Elanco Animal Health Inc (0001739104) (Issuer)

    12/15/25 4:43:23 PM ET
    $ELAN
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $ELAN
    $ZD
    SEC Filings

    View All

    $ELAN
    $ZD
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    SEC Form 10-K filed by Ziff Davis Inc.

    10-K - ZIFF DAVIS, INC. (0001084048) (Filer)

    2/24/26 5:04:28 PM ET
    $ZD
    Telecommunications Equipment
    Telecommunications

    SEC Form 10-K filed by Elanco Animal Health Incorporated

    10-K - Elanco Animal Health Inc (0001739104) (Filer)

    2/24/26 9:19:48 AM ET
    $ELAN
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Elanco Animal Health Incorporated filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits

    8-K - Elanco Animal Health Inc (0001739104) (Filer)

    2/24/26 6:28:19 AM ET
    $ELAN
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Elanco Animal Health upgraded by Piper Sandler

    Piper Sandler upgraded Elanco Animal Health from Neutral to Overweight

    1/22/26 8:20:23 AM ET
    $ELAN
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Barclays initiated coverage on Elanco Animal Health with a new price target

    Barclays initiated coverage of Elanco Animal Health with a rating of Overweight and set a new price target of $30.00

    12/9/25 8:46:01 AM ET
    $ELAN
    Biotechnology: Pharmaceutical Preparations
    Health Care

    KeyBanc Capital Markets initiated coverage on Elanco Animal Health with a new price target

    KeyBanc Capital Markets initiated coverage of Elanco Animal Health with a rating of Overweight and set a new price target of $27.00

    11/21/25 8:08:36 AM ET
    $ELAN
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $ELAN
    $ZD
    Financials

    Live finance-specific insights

    View All

    Elanco Animal Health Reports Fourth Quarter and Full Year 2025 Results

    Raising 2026 Innovation Target; Full Year 2026 Guidance of 4%-6% Organic Constant Currency Revenue Growth, 6%-9% Adjusted EBITDA Growth In Line with Investor Day OutlookFourth Quarter 2025 Financial Results:Revenue of $1,144 million, increased 12% on a reported basis; 9% in organic constant currencyReported Net Loss of $276 million, Adjusted Net Income of $64 millionAdjusted EBITDA of $189 million; Adjusted EBITDA Margin of 16.7%Reported EPS of $(0.56), Adjusted EPS of $0.13Full Year 2025 Financial Results:Exceeded innovation revenue target at $892 million; delivered all 'Big 6' blockbuster potential products by the end of 2025 with Befrena approval in Q4 2025Revenue of $4,715 million, incre

    2/24/26 6:27:00 AM ET
    $ELAN
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Ziff Davis Reports Fourth Quarter and Full Year 2025 Financial Results

    Ziff Davis, Inc. (NASDAQ:ZD) ("Ziff Davis" or "the Company") today reported unaudited financial results for the fourth quarter and year ended December 31, 2025. "In 2025, Ziff Davis grew Revenues, Adjusted EBITDA, and Adjusted diluted EPS, while generating almost $290 million in Free cash flow," said Vivek Shah, CEO of Ziff Davis. "We deployed $174 million in share repurchases during the year with the conviction that our share price does not adequately reflect the intrinsic value of our businesses." FOURTH QUARTER 2025 RESULTS Revenues (1) decreased to $406.7 million compared to $412.8 million for Q4 2024. Income from operations increased 9.6% to $86.0 million compared to $78.5 m

    2/23/26 6:00:00 PM ET
    $ZD
    Telecommunications Equipment
    Telecommunications

    Elanco Confirms Date and Conference Call for Fourth Quarter and Full Year 2025 Financial Results Announcement

    INDIANAPOLIS, Jan. 22, 2026 /PRNewswire/ -- Elanco Animal Health Incorporated (NYSE:ELAN) will announce its fourth quarter and full year 2025 financial results on Tuesday, February 24, 2026. Elanco will also conduct a conference call on that day with the investment community and media to further detail the company's performance. The conference call will begin at 8:00 a.m. Eastern Standard Time. Investors, media, and the general public can access a live webcast of the conference call through the link that will be posted on Elanco's website at https://investor.elanco.com/events-

    1/22/26 8:00:00 AM ET
    $ELAN
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $ELAN
    $ZD
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13G/A filed by Ziff Davis Inc.

    SC 13G/A - ZIFF DAVIS, INC. (0001084048) (Subject)

    11/12/24 5:57:23 PM ET
    $ZD
    Telecommunications Equipment
    Telecommunications

    Amendment: SEC Form SC 13G/A filed by Ziff Davis Inc.

    SC 13G/A - ZIFF DAVIS, INC. (0001084048) (Subject)

    11/4/24 2:15:05 PM ET
    $ZD
    Telecommunications Equipment
    Telecommunications

    SEC Form SC 13G filed by Ziff Davis Inc.

    SC 13G - ZIFF DAVIS, INC. (0001084048) (Subject)

    10/31/24 11:55:01 AM ET
    $ZD
    Telecommunications Equipment
    Telecommunications

    $ELAN
    $ZD
    Leadership Updates

    Live Leadership Updates

    View All

    Ziff Davis to Announce Fourth Quarter and Year-End 2025 Earnings

    Ziff Davis, Inc. (NASDAQ:ZD) will release its Fourth Quarter and Year-End 2025 Earnings at 6:00PM ET on Monday, February 23, 2026. Additionally, Ziff Davis invites the public, members of the press, the financial community, stockholders, and other interested parties to listen to a live audio Webcast of its Fourth Quarter and Year-End 2025 Earnings Call at 8:30AM ET on Tuesday, February 24, 2026. Vivek Shah, Chief Executive Officer, and Bret Richter, Chief Financial Officer, will host the call. Materials presented during the call will be posted on the Company's web site at ziffdavis.com and furnished as an exhibit to the Company's 8-K filed with the Securities and Exchange Commission pursua

    2/2/26 7:00:00 AM ET
    $ZD
    Telecommunications Equipment
    Telecommunications

    Elanco executive appointed as Neurizon's Board Observer

    MELBOURNE, Australia, Nov. 26, 2025 /PRNewswire/ -- Neurizon® Therapeutics Limited ((ASX: NUZ &, NUZOA, OTCQB:NUZTF) ("Neurizon" or "the Company"), a clinical-stage biotech company dedicated to advancing innovative treatments for neurodegenerative diseases, is pleased to announce the appointment of Ms Justine Conway as a Board Observer. Ms Conway currently serves as Global Head of Business Development at Elanco Animal Health ("Elanco") (NYSE:ELAN) and will participate in Neurizon's Board activities as Elanco's designated representative. The appointment highlights the strength of Neurizon's relationship with Elanco, as well as Elanco's ongoing partnership with Neurizon. The appointment follo

    11/26/25 6:15:00 PM ET
    $ELAN
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Inseego Strengthens Board of Directors with Experienced Operational Leaders in Carrier, AI, and SaaS

    SAN DIEGO, Nov. 03, 2025 (GLOBE NEWSWIRE) -- Inseego Corp. (NASDAQ:INSG), a global leader in 5G mobile broadband and 5G fixed wireless access (FWA) solutions, announced today that Nabil Bukhari and Stephen Bye are joining its Board of Directors. Both operating executives bring extensive experience in wireless networking, SaaS, and AI, combined with a strong record of driving transformation and go-to-market execution. Their backgrounds in product innovation, platform growth, and business model monetization align directly with Inseego's strategy to expand its leadership in enterprise connectivity and grow into new markets. "Nabil and Stephen are exceptional executives and operational leader

    11/3/25 8:00:00 AM ET
    $EXTR
    $INSG
    $SATS
    Computer Communications Equipment
    Telecommunications
    Telecommunications Equipment
    Consumer Discretionary